A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infections

Inge C. Gyssens*, Matthew Dryden, Peter Kujath, Dilip Nathwani, Nicolaas Schaper, Barbara Hampel, Peter Reimnitz, Jeff Alder, Pierre Arvis

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Web of Science)
Original languageEnglish
Pages (from-to)2632-2642
JournalJournal of Antimicrobial Chemotherapy
Issue number11
Publication statusPublished - Nov 2011


  • beta-lactams
  • randomized controlled trials
  • soft tissue infections
  • fluoroquinolones
  • sequential therapy

Cite this